ICD-10 Coding for Polymyositis(D86.0, D86.0N, G72.41)
Comprehensive guide on ICD-10 coding for polymyositis, including subcodes for organ involvement and documentation requirements.
Complete code families applicable to Polymyositis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| M33.22 | Polymyositis with myopathy | Use when muscle biopsy confirms CD8+ T-cell infiltration and MHC class I overexpression. |
|
| M33.21 | Polymyositis with respiratory involvement | Use when respiratory symptoms are documented with PFTs and imaging. |
|
| M33.29 | Polymyositis with other organ involvement | Use when other organ systems are involved, confirmed by specific tests. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPolymyositis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Polymyositis.
Documenting 'muscle weakness' without specifics
Impact
Clinical: Leads to misdiagnosis or inappropriate treatment., Regulatory: Increases risk of coding audits., Financial: Potential for denied claims.
Mitigation
Always specify muscle groups affected, Include lab and biopsy results
Using M33.2 without specifying organ involvement
Impact
Reimbursement: Incorrect coding can lead to lower DRG payments., Compliance: Increases risk of audit and denial., Data Quality: Leads to inaccurate clinical data representation.
Mitigation
Always specify organ involvement using subcodes like M33.21 or M33.29.
Unspecified polymyositis coding
Impact
Using unspecified codes increases audit risk.
Mitigation
Always use specific subcodes when organ involvement is documented.